Literature DB >> 21903287

Target volume delineation variation in radiotherapy for early stage rectal cancer in the Netherlands.

Jasper Nijkamp1, Danielle F M de Haas-Kock, Jannet C Beukema, Karen J Neelis, Dankert Woutersen, Heleen Ceha, Tom Rozema, Annerie Slot, Hanneke Vos-Westerman, Martijn Intven, Patty H Spruit, Yvette van der Linden, Debby Geijsen, Karijn Verschueren, Marcel B van Herk, Corrie A M Marijnen.   

Abstract

PURPOSE: The aim of this study was to measure and improve the quality of target volume delineation by means of national consensus on target volume definition in early-stage rectal cancer. METHODS AND MATERIALS: The CTV's for eight patients were delineated by 11 radiation oncologists in 10 institutes according to local guidelines (phase 1). After observer variation analysis a workshop was organized to establish delineation guidelines and a digital atlas, with which the same observers re-delineated the dataset (phase 2). Variation in volume, most caudal and cranial slice and local surface distance variation were analyzed.
RESULTS: The average delineated CTV volume decreased from 620 to 460 cc (p<0.001) in phase 2. Variation in the caudal CTV border was reduced significantly from 1.8 to 1.2 cm SD (p=0.01), while it remained 0.7 cm SD for the cranial border. The local surface distance variation (cm SD) reduced from 1.02 to 0.74 for anterior, 0.63 to 0.54 for lateral, 0.33 to 0.25 for posterior and 1.22 to 0.46 for the sphincter region, respectively.
CONCLUSIONS: The large variation in target volume delineation could significantly be reduced by use of consensus guidelines and a digital delineation atlas. Despite the significant reduction there is still a need for further improvement.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21903287     DOI: 10.1016/j.radonc.2011.08.011

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  17 in total

1.  Development of a software for quantitative evaluation radiotherapy target and organ-at-risk segmentation comparison.

Authors:  Jayashree Kalpathy-Cramer; Musaddiq Awan; Steven Bedrick; Coen R N Rasch; David I Rosenthal; Clifton D Fuller
Journal:  J Digit Imaging       Date:  2014-02       Impact factor: 4.056

Review 2.  Improving radiotherapy quality assurance in clinical trials: assessment of target volume delineation of the pre-accrual benchmark case.

Authors:  S Gwynne; E Spezi; D Sebag-Montefiore; S Mukherjee; E Miles; J Conibear; J Staffurth
Journal:  Br J Radiol       Date:  2013-02-07       Impact factor: 3.039

3.  Auto-segmentation of the brachial plexus assessed with TaCTICS - a software platform for rapid multiple-metric quantitative evaluation of contours.

Authors:  Musaddiq Awan; Brandon Alan Dyer; Jayashree Kalpathy-Cramer; Eva Bongers; Max Dahele; Jinzhong Yang; Gary V Walker; Nikhil G Thaker; Emma Holliday; Andrew J Bishop; Charles R Thomas; David I Rosenthal; Clifton David Fuller
Journal:  Acta Oncol       Date:  2014-10-03       Impact factor: 4.089

4.  Consequences of anorectal cancer atlas implementation in the cooperative group setting: radiobiologic analysis of a prospective randomized in silico target delineation study.

Authors:  Panayiotis Mavroidis; Drosoula Giantsoudis; Musaddiq J Awan; Jasper Nijkamp; Coen R N Rasch; Joop C Duppen; Charles R Thomas; Paul Okunieff; William E Jones; Lisa A Kachnic; Niko Papanikolaou; Clifton D Fuller
Journal:  Radiother Oncol       Date:  2014-07-01       Impact factor: 6.280

Review 5.  Anal cancer: are we making progress?

Authors:  Ajay Aggarwal; Simon Duke; Rob Glynne-Jones
Journal:  Curr Oncol Rep       Date:  2013-04       Impact factor: 5.075

6.  Automatic segmentation software in locally advanced rectal cancer: READY (REsearch program in Auto Delineation sYstem)-RECTAL 02: prospective study.

Authors:  Maria A Gambacorta; Luca Boldrini; Chiara Valentini; Nicola Dinapoli; Gian C Mattiucci; Giuditta Chiloiro; Danilo Pasini; Stefania Manfrida; Nicola Caria; Bruce D Minsky; Vincenzo Valentini
Journal:  Oncotarget       Date:  2016-07-05

7.  Considerable interobserver variation in delineation of pancreatic cancer on 3DCT and 4DCT: a multi-institutional study.

Authors:  Eva Versteijne; Oliver J Gurney-Champion; Astrid van der Horst; Eelco Lens; M Willemijn Kolff; Jeroen Buijsen; Gati Ebrahimi; Karen J Neelis; Coen R N Rasch; Jaap Stoker; Marcel van Herk; Arjan Bel; Geertjan van Tienhoven
Journal:  Radiat Oncol       Date:  2017-03-23       Impact factor: 3.481

8.  Uncertainties in target volume delineation in radiotherapy - are they relevant and what can we do about them?

Authors:  Barbara Segedin; Primoz Petric
Journal:  Radiol Oncol       Date:  2016-05-09       Impact factor: 2.991

9.  A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPARC' trial protocol.

Authors:  Daniel L P Holyoake; Elizabeth Ward; Derek Grose; David McIntosh; David Sebag-Montefiore; Ganesh Radhakrishna; Neel Patel; Michael Silva; Somnath Mukherjee; Victoria Y Strauss; Lang'o Odondi; Emmanouil Fokas; Alan Melcher; Maria A Hawkins
Journal:  BMC Cancer       Date:  2016-09-13       Impact factor: 4.430

10.  Conformity analysis to demonstrate reproducibility of target volumes for Margin-Intense Stereotactic Radiotherapy for borderline-resectable pancreatic cancer.

Authors:  Daniel L P Holyoake; Maxwell Robinson; Derek Grose; David McIntosh; David Sebag-Montefiore; Ganesh Radhakrishna; Neel Patel; Mike Partridge; Somnath Mukherjee; Maria A Hawkins
Journal:  Radiother Oncol       Date:  2016-08-09       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.